Jennifer B. Marks

10.7k total citations · 2 hit papers
49 papers, 3.4k citations indexed

About

Jennifer B. Marks is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Jennifer B. Marks has authored 49 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 14 papers in Genetics. Recurrent topics in Jennifer B. Marks's work include Diabetes Management and Research (20 papers), Diabetes and associated disorders (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Jennifer B. Marks is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes and associated disorders (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Jennifer B. Marks collaborates with scholars based in United States, Australia and Canada. Jennifer B. Marks's co-authors include Jay S. Skyler, Philip Raskin, Carla J. Greenbaum, Peter A. Gottlieb, Dorothy J. Becker, Antoinette Moran, Desmond Schatz, Diane K. Wherrett, Robin Goland and Darrell M. Wilson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Jennifer B. Marks

48 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

2009 781 citations Mark D. Pescovitz, Carla J. Greenbaum et al. New England Journal of Medicine profile →
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

2011 428 citations Tihamer Orban, Brian N. Bundy et al. The Lancet profile →

Peers

Countries citing papers authored by Jennifer B. Marks

Since Specialization

Citations

This map shows the geographic impact of Jennifer B. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer B. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer B. Marks more than expected).

Fields of papers citing papers by Jennifer B. Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer B. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer B. Marks. The network helps show where Jennifer B. Marks may publish in the future.

Co-authorship network of co-authors of Jennifer B. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer B. Marks. A scholar is included among the top collaborators of Jennifer B. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer B. Marks. Jennifer B. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Weight status and obesity-related dietary behaviours among culturally and linguistically diverse (CALD) children in Victoria, Australia 2019 ·BMC Pediatrics ·(unknown), Kristy A. Bolton, Claudia Strugnell, Steven Allender, Jennifer B. Marks	13
2	Protocol for an economic evaluation of WHO STOPS childhood obesity stepped-wedge cluster randomised controlled trial 2018 ·BMJ Open ·Rohan Sweeney, Marj Moodie, Phuong Nguyen, Penny Fraser, Kristy A. Bolton, Andrew Brown, Jennifer B. Marks, (unknown), Claudia Strugnell, Colin Bell, Lynne Millar, Liliana Orellana, Steven Allender	15
3	Social network analysis of stakeholder networks from two community-based obesity prevention interventions 2018 ·PLoS ONE ·(unknown), Melanie Nichols, Ariella R. Korn, Lynne Millar, Jennifer B. Marks, (unknown), Mark C. Pachucki, Boyd Swinburn, Steven Allender, Christina D. Economos	30
4	The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes 2017 ·Diabetologia ·(unknown), Heba M. Ismail, Ping Xu, Ingrid Libman, Dorothy J. Becker, Jennifer B. Marks, Jay S. Skyler, Jerry P. Palmer, Jay M. Sosenko	25
5	Health benefits of hard martial arts in adults: a systematic review 2017 ·Journal of Sports Sciences ·(unknown), Jennifer B. Marks, Isaac Estevan, Lisa M. Barnett	77
6	Friendship Network Characteristics Are Associated with Physical Activity and Sedentary Behavior in Early Adolescence 2015 ·PLoS ONE ·Jennifer B. Marks, Kayla de la Haye, Lisa M. Barnett, Steven Allender	48
7	Change of School in Early Adolescence and Adverse Obesity-Related Dietary Behavior: A Longitudinal Cohort Study, Victoria, Australia, 2013–2014 2015 ·Preventing Chronic Disease ·Jennifer B. Marks, Lisa M. Barnett, Steven Allender	13
8	Using Social Network Analysis to Identify Key Child Care Center Staff for Obesity Prevention Interventions: A Pilot Study 2013 ·Journal of Obesity ·Jennifer B. Marks, Lisa M. Barnett, (unknown), Penelope Hawe, Steven Allender	19
9	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recentonset type 1 diabetes: A randomized double-blind trial 2013 ·Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, (unknown), Stephen E. Gitelman, Robin Goland, (unknown), Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Andrew E. Moran, (unknown), Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler	4
10	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial 2011 ·The Lancet ·Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Tihamer Orban, Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler	274
11	The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial 2011 ·Journal of Diabetes and its Complications ·William C. Duckworth, Carlos Abraira, Thomas Moritz, Stephen N. Davis, Nicholas Emanuele, Steven Goldman, Rodney A. Hayward, Grant D. Huang, Jennifer B. Marks, Peter D. Reaven, Domenic J. Reda, Stuart Warren, Franklin J. Zieve	105
12	Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial breakdown → 2011 ·The Lancet ·Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler	428
13	Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function breakdown → 2009 ·New England Journal of Medicine ·Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler	781
14	Metabolic Syndrome: To Be or Not To Be? 2006 ·Clinical Diabetes ·Jennifer B. Marks	1
15	Validation of the insulin sensitivity index (ISI0,120): comparison with other measures 2000 ·Diabetes Research and Clinical Practice ·M. Gutt, Catherine L. Davis, Susan B. Spitzer, María M. Llabre, Mahendra Kumar, (unknown), Neil Schneiderman, Jay S. Skyler, Jennifer B. Marks	374
16	Cardiovascular risk in diabetes 2000 ·Journal of Diabetes and its Complications ·Jennifer B. Marks, P. Raskin	86
17	History of Gestational Diabetes, Insulin Resistance and Coronary Risk 1999 ·Journal of Diabetes and its Complications ·Catherine L. Davis, M. Gutt, María M. Llabre, Jennifer B. Marks, Mary J. O’Sullivan, JoNell Potter, (unknown), Mahendra Kumar, N. Schneiderman, Marc D. Gellman, Jay S. Skyler	55
18	NEPHROPATHY AND HYPERTENSION IN DIABETES 1998 ·Medical Clinics of North America ·Jennifer B. Marks, Philip Raskin	27
19	Resting parasympathetic status and cardiovascular response to orthostatic and behavioral challenges in type I insulin-dependent diabetes mellitus 1994 ·International Journal of Behavioral Medicine ·Barry E. Hurwitz, (unknown), Jennifer B. Marks, Neil Schneiderman, (unknown), (unknown), Annette M. La Greca, Jay S. Skyler	1
20	Immunotherapy of Type I Diabetes Mellitus* 1991 ·The Journal of Clinical Endocrinology & Metabolism ·Jennifer B. Marks, Jay S. Skyler	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact